Kan Yonemori

Kan Yonemori

UNVERIFIED PROFILE

Are you Kan Yonemori?   Register this Author

Register author
Kan Yonemori

Kan Yonemori

Publications by authors named "Kan Yonemori"

Are you Kan Yonemori?   Register this Author

100Publications

2306Reads

24Profile Views

Real-world data on initial treatment strategies for older adult patients with endometrial cancer in Japan.

Cancer Chemother Pharmacol 2019 Nov 4;84(5):1051-1058. Epub 2019 Sep 4.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-019-03938-8DOI Listing
November 2019

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines.

Clin Pharmacol Ther 2019 Oct 29;106(4):803-809. Epub 2019 Apr 29.

Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.1442DOI Listing
October 2019

SMARCB-1 deficient squamous cell carcinoma of a mediastinal cyst.

Pathol Int 2018 Oct 14;68(10):563-566. Epub 2018 Sep 14.

Department of Pathology and Clinical Laboratories, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/pin.12720
Publisher Site
http://dx.doi.org/10.1111/pin.12720DOI Listing
October 2018

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study.

Cancer Chemother Pharmacol 2018 08 5;82(2):275-283. Epub 2018 Jun 5.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3617-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060805PMC
August 2018

BRCA Gene Mutations and Poly(ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer.

Adv Exp Med Biol 2017 ;1026:271-286

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-981-10-6020-5_13DOI Listing
July 2018

Symptom management: the utility of regional cooling for hand-foot syndrome induced by pegylated liposomal doxorubicin in ovarian cancer.

Support Care Cancer 2018 Jul 25;26(7):2161-2166. Epub 2018 Jan 25.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4054-zDOI Listing
July 2018

Efficacy and Safety of Pazopanib for Recurrent or Metastatic Solitary Fibrous Tumor.

Oncology 2018 3;94(6):340-344. Epub 2018 Apr 3.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000486623DOI Listing
June 2018

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma.

Ther Innov Regul Sci 2018 05 8;52(3):334-338. Epub 2017 Sep 8.

2 Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2168479017728989DOI Listing
May 2018

TERT promoter hotspot mutations in breast cancer.

Breast Cancer 2018 May 8;25(3):292-296. Epub 2017 Dec 8.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-017-0825-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906518PMC
May 2018

Neoadjuvant crizotinib in ALK-rearranged inflammatory myofibroblastic tumor of the urinary bladder: A case report.

Int J Surg Case Rep 2018 1;48:1-4. Epub 2018 May 1.

Department of Urology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0054, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2018.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6019858PMC
May 2018

[I. Clinical Development and Prospect of Chemotherapy for Uterine Carcinosarcoma].

Gan To Kagaku Ryoho 2018 Feb;45(2):234-238

Dept. of Gynecologic Oncology, Saitama Medical University International Medical Center.

View Article

Download full-text PDF

Source
February 2018

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose-finding trials.

Cancer Sci 2018 Jan 8;109(1):207-214. Epub 2017 Dec 8.

Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Rockville, MD, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.13436
Publisher Site
http://dx.doi.org/10.1111/cas.13436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765308PMC
January 2018

Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine Carcinoma.

Oncology 2017 19;93(3):177-182. Epub 2017 May 19.

Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000475669DOI Listing
December 2017

Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.

Am J Surg Pathol 2017 Nov;41(11):1523-1531

Departments of *Pathology and Clinical Laboratories §Urology ∥Musculoskeletal Oncology ¶Medical Oncology, National Cancer Center Hospital ‡Rare Cancer Center, National Cancer Center Hospital †Department of Pathology, the University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000910DOI Listing
November 2017

Visualization of HER2-specific breast cancer intratumoral heterogeneity using Cu-DOTA-trastuzumab PET.

Eur J Nucl Med Mol Imaging 2017 11 3;44(12):2146-2147. Epub 2017 Aug 3.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-Ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3781-6DOI Listing
November 2017

The Prognostic Impact of the Pathological Response to Neoadjuvant Dose-Dense Therapy for Ovarian Carcinoma.

Int J Gynecol Cancer 2017 11;27(9):1850-1855

*Department of Medical Oncology, Chiba University, Chiba; and Departments of †Breast and Medical Oncology, ‡Pathology, §Pharmacy, and ∥Gynecology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000001107DOI Listing
November 2017

CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study.

Histopathology 2017 Sep 5;71(3):461-469. Epub 2017 Jul 5.

Department of Pathology and Clinical Laboratories, National Cancer Centre Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13252DOI Listing
September 2017

Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer.

Cancer Chemother Pharmacol 2017 Jul 24;80(1):127-134. Epub 2017 May 24.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-017-3342-5DOI Listing
July 2017

Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin.

Adv Ther 2017 07 25;34(7):1556-1571. Epub 2017 May 25.

Department of Orthopaedic Surgery, National Hospital Organization, Osaka National Hospital, Osaka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12325-017-0561-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5504216PMC
July 2017

Drug induced interstitial lung disease in oncology phase I trials.

Cancer Sci 2016 Dec;107(12):1830-1836

Investigational Drug Branch, Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institute of Health, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.13087
Publisher Site
http://dx.doi.org/10.1111/cas.13087DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198943PMC
December 2016

Feasibility of dose-dense paclitaxel/carboplatin therapy in elderly patients with ovarian, fallopian tube, or peritoneal cancer.

Cancer Chemother Pharmacol 2016 10 13;78(4):745-52. Epub 2016 Aug 13.

Department of Breast and Clinical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3100-0DOI Listing
October 2016

Safety and tolerability of the olaparib tablet formulation in Japanese patients with advanced solid tumours.

Cancer Chemother Pharmacol 2016 Sep 15;78(3):525-31. Epub 2016 Jul 15.

Department of Gastroenterology, National Hospital Organization Hokkaido Cancer Center, Hokkaido, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3106-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5010592PMC
September 2016

Ifosfamide and Etoposide Chemotherapy in the Treatment of Recurrent/Refractory Rhabdomyosarcoma in Adults.

Anticancer Res 2016 May;36(5):2429-32

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan

View Article

Download full-text PDF

Source
May 2016

Safety and tolerability of AZD5363 in Japanese patients with advanced solid tumors.

Cancer Chemother Pharmacol 2016 Apr 1;77(4):787-95. Epub 2016 Mar 1.

Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2987-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819940PMC
April 2016

Molecular imaging using PET for breast cancer.

Breast Cancer 2016 Jan 28;23(1):24-32. Epub 2015 Apr 28.

Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-015-0613-zDOI Listing
January 2016

A descriptive analysis of post-chemotherapy development of interstitial lung disease using spontaneous reporting data in Japan.

Curr Drug Saf 2014 ;9(3):220-6

Biostatistics Section, Center for Advanced Medicine and Clinical Research, Graduate School of Medicine, Nagoya University, 65 Tsurumai-cho, Showa-ku, Nagoya 466- 8560, Japan.

View Article

Download full-text PDF

Source
August 2015

Clinicopathologic analysis of spindle cell/sclerosing rhabdomyosarcoma.

Pediatr Blood Cancer 2015 Jun 31;62(6):1011-6. Epub 2014 Dec 31.

Division of Pediatric Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25367DOI Listing
June 2015

Japanese universal health care faces a crisis in cancer treatment.

Lancet Oncol 2015 Mar;16(3):251-2

Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(15)70007-0DOI Listing
March 2015

[Perirenal malignant perivascular epithelioid cell tumor originating from right retroperitoneum: a case report].

Hinyokika Kiyo 2014 Dec;60(12):627-30

The Department of Urology, Graduate School of Medicine, University of the Ryukyus.

View Article

Download full-text PDF

Source
December 2014

Exploring Ethnic Differences in Toxicity in Early-Phase Clinical Trials for Oncology Drugs.

Ther Innov Regul Sci 2014 Sep;48(5):644-650

4 Office of Vaccines and Blood Products, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2168479014524582DOI Listing
September 2014

Alternative two-step matrix application method for imaging mass spectrometry to avoid tissue shrinkage and improve ionization efficiency.

J Mass Spectrom 2013 Dec;48(12):1285-90

Division of Translational Research, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan; Division of Clinical Pharmacology Group for Translational Research Support Core, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 1040045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jms.3288DOI Listing
December 2013

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer.

Cancer Chemother Pharmacol 2013 May 5;71(5):1369-74. Epub 2013 Apr 5.

Department of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2137-6DOI Listing
May 2013

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer.

Int J Clin Oncol 2013 Feb 22;18(1):132-8. Epub 2011 Nov 22.

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-011-0352-xDOI Listing
February 2013

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.

Cancer Chemother Pharmacol 2012 Sep 18;70(3):391-7. Epub 2012 Jul 18.

Department of Medical Oncology and Breast Oncology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-012-1920-0DOI Listing
September 2012

Immunohistochemical profile for unknown primary adenocarcinoma.

PLoS One 2012 27;7(1):e31181. Epub 2012 Jan 27.

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0031181PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267772PMC
July 2012

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection.

Oncology 2012 12;82(4):228-33. Epub 2012 Apr 12.

Department of Breast Oncology and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000336904DOI Listing
June 2012

Efficacy of taxane regimens in patients with metastatic angiosarcoma.

Eur J Dermatol 2011 Jul-Aug;21(4):539-45

Departments of Breast and Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://www.john-libbey-eurotext.fr/medline.md?doi=10.1684/ej
Publisher Site
http://dx.doi.org/10.1684/ejd.2011.1403DOI Listing
December 2011

Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma.

Eur J Obstet Gynecol Reprod Biol 2011 Dec 10;159(2):394-8. Epub 2011 Aug 10.

Breast and Medical Oncology Division, National Cancer Centre Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S030121151100402
Publisher Site
http://dx.doi.org/10.1016/j.ejogrb.2011.07.001DOI Listing
December 2011

The notorious "drug lag" for oncology drugs in Japan.

Invest New Drugs 2011 Aug 1;29(4):706-12. Epub 2011 Feb 1.

Breast and Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, 103-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-011-9638-0DOI Listing
August 2011

Second-line chemotherapy in patients with primary unknown cancer.

J Cancer Res Clin Oncol 2011 Aug 11;137(8):1185-91. Epub 2011 May 11.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00432-011-0983
Web Search
http://link.springer.com/10.1007/s00432-011-0983-3
Publisher Site
http://dx.doi.org/10.1007/s00432-011-0983-3DOI Listing
August 2011

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

Med Oncol 2011 Jun 31;28(2):434-40. Epub 2010 Mar 31.

Breast and Medical Oncology Division, National Cancer Center Hospital, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-010-9497-0DOI Listing
June 2011

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors.

Oncology 2010 25;78(1):34-9. Epub 2010 Feb 25.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/288647
Publisher Site
http://dx.doi.org/10.1159/000288647DOI Listing
April 2010

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

Jpn J Clin Oncol 2009 Jul 24;39(7):456-9. Epub 2009 Apr 24.

Division of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyp034DOI Listing
July 2009

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death.

Oncologist 2009 Jul 11;14(7):752-9. Epub 2009 Jul 11.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2008-0257DOI Listing
July 2009

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate.

Int J Clin Oncol 2008 Dec 18;13(6):555-8. Epub 2008 Dec 18.

National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-008-0782-2DOI Listing
December 2008

Immunohistochemical profiles of brain metastases from breast cancer.

J Neurooncol 2008 Nov 23;90(2):223-8. Epub 2008 Jul 23.

Breast and Medical Oncology Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-008-9654-xDOI Listing
November 2008